Sitting indoors seeking relief from the summer heat? Here’s a montage of cool and refreshing health care items, including CPOE systems, accountable care organizations, Massachusetts’ reform experience, reducing imaging, and medical management trends.
We light up the sky with a scintillating selection of health care bombshells. Okay, maybe not that great, but some hopefully useful info on the VA’s health information system, MRIs and emergency cardiac care, business method and process patents, end-of-life care, actuaries’ views on how to control costs and, of course, more issues in Massachusetts.
A critical component of personalized medicine is various molecular diagnostic tests. AHRQ has issued a lengthy report on the state of these tests, examining their quality and clinical utility.
The Commonwealth Fund issues one of its regular reports designed to demonstrate how bad the US health system is compared to those of other developed countries. Unfortunately, the report is based almost exclusively on subjective survey data and fails to provide any adjustments to create a truer picture of the status of our system vis-a-vis others.
States that supposedly led the way on health care reform are finding out it was the bleeding edge that they were on. Insurers are always the easy target, but bashing them won’t solve the underlying cost problem. If the federal bill actually is implemented, the experience of these states will likely be replicated nationally.
The Centers for Disease Control issues a massive compendium of health facts and information called Health United States 2009. In addition to basic information regarding health care, it has some description and analysis of particular issues such as use of medical technology.
Much concern has been expressed about whether the FDA may make changes to the 510(k) and other regulations that hinder speed to market for medical device companies. A recently finalized guidance may actually help those firms.
Personalized medicine is widely promoted as the future of health care. Several government agencies are examining the implications of growth in genomic knowledge and its application to medical practice. CDC and NIH are intending to create a Genomics Knowledge Synthesis Center.